References
- Beasley R, Ellwood P, Asher, I. International patterns of the prevalence of pediatric asthma the ISAAC program. Pediatr Clin North Am 2003;50:539–53
- Takahashi, K. Chemical contamination of the environment and development of allergic and autoimmune diseases. Nihon Rinsho 2010;68:551–62
- Kolarik B, Naydenov K, Larsson M, et al. The association between phthalates in dust and allergic diseases among Bulgarian children. Environ Health Perspect 2008;116:98–103
- Bornehag CG, Sundell J, Weschler CJ, et al. The association between asthma and allergic symptoms in children and phthalates in house dust: a nested case-control study. Environ Health Perspect 2004;112:1393–7
- Takano H, Yanagisawa R, Inoue K, et al. Di-(2-ethylhexyl) phthalate enhances atopic dermatitis-like skin lesions in mice. Environ Health Perspect 2006;114:1266–9
- Larsen ST, Hansen JS, Hansen EW, et al. Airway inflammation and adjuvant effect after repeated airborne exposures to di-(2-ethylhexyl)phthalate and ovalbumin in BALB/c mice. Toxicology 2007;235:119–29
- Larsen ST, Nielsen GD. The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism. Toxicol Lett 2007;170:223–8
- Tanaka M, Inoue K, Momoi T, Takano H. In vivo immunoamplifying effects of di-(2-ethylhexyl) phthalate on cytokine response. Immunopharmacol Immunotoxicol 2013;35:147–50
- Potera, C. Autoimmune disease: phthalate linked to lupus in mice. Environ Health Perspect 2005;113:A809
- Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8:161–76
- Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22–7
- Kim SY, Yoon SJ, Jo MW, et al. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy 2010;24:e110–13
- Kobayashi T. Exposure to diesel exhaust aggravates nasal allergic reaction in guinea pigs. Am J Respir Crit Care Med 2000;162:352–6
- Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248–50
- Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19–26
- Defrance T, Carayon P, Billian G, et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994;179:135–43
- McKenzie GJ, Emson CL, Bell SE, et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998;9:423–32
- Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258–61
- Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779–88
- Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004;202:175–90
- Pawankar RU, Okuda M, Hasegawa S, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059–67
- Ghaffar O, Laberge S, Jacobson MR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17:17–24
- Miyahara S, Miyahara N, Matsubara S, et al. IL-13 is essential to the late-phase response in allergic rhinitis. J Allergy Clin Immunol 2006;118:1110–16